(Hypertension. 1999;34:790-794.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
From the Department of Physical Education, Biosciences Institute (A.Z.), Paulista State University, Rio Claro (SP) and the Department of Pharmacology, Faculty of Medical Sciences (S.K.P.C., S.R.R., L.P.N., C.F. de O., E.A., G. De N.); and Department of Histology and Embryology, Biology Institute, State University of Campinas, (I.M.S. De L.), Campinas (SP), Brazil.
Correspondence to Angelina Zanesco, PhD, Department of Physical Education, Biosciences Institute, Paulista State University, Av 24A No. 1515, Bela Vista, CEP 13506-900, Rio Claro (SP), Brazil. E-mail azanesco{at}bestway.com.br
| Abstract |
|---|
|
|
|---|
Key Words: capsaicin receptors, muscarinic receptors, adrenergic, beta neuropeptides peptides
| Introduction |
|---|
|
|
|---|
In the heart, capsaicin increases contractile force and spontaneous heart rate3 as well as evokes coronary vasodilation through CGRP release.11 12 Previous studies reported the presence of CGRP in the heart, predominantly in the right atria, followed by the left atria and right and left ventricles,3 13 where it causes concentration-dependent and long-lasting positive inotropic and chronotropic effects in several species,9 14 15 16 17 including humans.18 Although CGRP has also been described as a potent hypertrophic factor for cardiomyocytes,19 no study has been performed to investigate the effect of CGRP depletion on cardiomyocyte size. The existence of interactions of sympathetic and parasympathetic nerves with sensory fibers in in vitro20 21 and in vivo22 preparations has been reported.23 In this study, pretreatment of neonate rats with capsaicin was performed and the rats were used at adult ages. We then evaluated the following parameters in the heart: (1) cardiomyocyte size, (2) basal and stimulated coronary flow in vitro, and (3) chronotropic and inotropic responses of ß-adrenoceptors and muscarinic agonists as well as CGRP, with both whole rat isolated heart and isolated right atria.
| Methods |
|---|
|
|
|---|
Langendorff Preparation
Male Wistar rats (weight, 250 to 350 g) were
anesthetized with sodium pentobarbital (Sagatal; 50 mg/kg IP)
and given heparin (500 IU/kg IP) 5 minutes before thoracotomy. The
hearts were rapidly excised and mounted on a Langendorff
apparatus and perfused at constant pressure (65
mm Hg) with oxygenated (95% O2/5%
CO2) Krebs-Henseleit solution containing (in
mmol/L) NaCl 118, KCl 4.7,
KH2PO4 1.2,
MgSO4 1.2, CaCl2 2.5,
NaHCO3 25, and glucose 11, pH 7.4, at 37°C.
Left ventricular developed pressure (LVDP) (mm Hg) and
heart rate (HR) (bpm) were recorded via a latex balloon inserted
into the left ventricle (basal end-diastolic pressure,
5 mm Hg). A polyethylene cannula was then connected to a
pressure transducer (model PRC 21/3, Ugo Basile) and a 2-channel
recorder (Gemini 7070, Ugo Basile). The preparations were allowed
to stabilize for 30 minutes. Coronary flow (mL/min) was
measured manually by 15-second timed collections of the
coronary effluent.
Functional Assays With Isolated Right Atria
Animals were anesthetized with halothane, and the hearts
were rapidly removed. The right atria were isolated and mounted in a
water-jacketed tissue chamber (10-mL volume) containing Krebs-Henseleit
solution, pH 7.3 to 7.5, at 37°C and gassed with 95%
O2/5% CO2. The composition
of the Krebs-Henseleit solution was as follows (mmol/L): NaCl 124, KCl
4.75, MgSO4 1.30, CaCl2
2.25, NaHCO3 25.0,
NaH2PO4 0.6, dextrose 10.0,
sodium ascorbate 0.3, and disodium EDTA 0.03. Ascorbate and EDTA were
added to inhibit the oxidation of
catecholamines.24 To block the neuronal and
extraneuronal uptake of catecholamines, both
phenoxybenzamine (10 µmol/L; Sigma Chemical Co) and
17ß-hydroxyestradiol (5 µmol/L; Sigma Chemical Co) were added
to the tissue bath.25
Construction and Analyses of Concentration-Response
Curves
Concentration-response curves for the positive and negative
chronotropic actions of isoproterenol, norepinephrine, rat
CGRP, carbachol, and pilocarpine (all Sigma Chemical Co) were
constructed by the cumulative variation of agonist concentration at
one-half log unit increments.26
All concentration-response data were evaluated for a fit to a logistic
function in the following form:
![]() |
is the response observed in the
absence of added agonist. Nonlinear regression analyses to
determine the parameters Emax, log
EC50, and n were performed with GraphPad Prism
(GraphPad Software) with the constraint that
=zero.
Stereological Procedures
Stereological analysis was performed according to the
method described by Aherne.27 Formalin-fixed left
ventricle and septum were cut into 5 equidistant rings perpendicular to
the long axis of the ventricle. The rings were then embedded in
paraffin, and 5-µm sections were stained with Masson's trichrome.
Analysis of the slides was performed in blinded fashion on a
light microscope (Zeiss), and the relative volume occupied by each
element of the ventricle (myocardial fibers and fibrous tissue) was
measured with a special ocular apparatus containing a
25-point reticulum (5 parallel lines with 5 points each, kpl x8,
Zeiss). To determine cardiomyocyte size, 15 cells
randomly selected from the subepicardial, midmyocardial, and
subendocardial regions were measured for each animal from the different
experimental groups. For counting, 50 microscopic fields were
evaluated, and the relative volume (Ppi) occupied by each component was
calculated as follows: Ppi=p/P-R, where p is the number of
reticular points hitting each cardiac element, P is the total number of
reticular points, and R is the number of points hitting artifactual
retraction areas.
Blood Pressure Measurement
The systolic blood pressure was measured by a modified
tail-cuff method in awake animals.28 The measurements were
performed 24 hours before the animals were killed.
Statistical Analysis
All values are expressed as mean±SEM. The program InStat
(GraphPad Software) was used for statistical analyses. When
appropriate, 1-way ANOVA followed by a Bonferroni multiple comparisons
post hoc test was performed to determine whether the treatments had an
effect. In some cases, a paired or unpaired Student's t
test was used. P<0.05 was accepted as significant.
| Results |
|---|
|
|
|---|
|
Whole Heart Preparations
Bolus injection of norepinephrine (0.6 nmol) caused
similar increases in LVDP and HR in both control and capsaicin-treated
animals (Table 2).
|
Capsaicin pretreatment significantly reduced basal coronary
flow by
18% (P<0.05; Table 2). Bolus
injection of norepinephrine (1.0 nmol) caused a significant
decrease in coronary flow in the control group at 0.25 minutes
after injection (35% reduction), whereas in capsaicin-treated rats the
reduction in coronary flow by norepinephrine was
attenuated (18.7% reduction; Table 2).
Isolated Right Atria
Addition of capsaicin (1 µmol/L) to the organ bath caused a
positive chronotropic response in isolated right atria of the control
group (44±4 bpm) that was attenuated by
45% (P<0.05)
in capsaicin-treated rats (20±2 bpm).
Chronotropic responses to both ß-adrenoceptor (isoproterenol and norepinephrine) and muscarinic (carbachol and pilocarpine) agonists are illustrated in the Figure. There was no significant shift of the concentration-response curves for norepinephrine between control and capsaicin groups (Figure, panel A). With respect to isoproterenol, although there was a tendency for a rightward shift in the concentration-response curves, the differences between both groups were not significant (Figure, panel B). The potency of muscarinic agonists was also unaffected by capsaicin pretreatment in isolated right atria (Figure, panels C and D).
|
Rat CGRP induced concentration-dependent positive chronotropic effects
of rat right atria that were
30% of maximum response for
isoproterenol and norepinephrine, as observed in either
control or capsaicin groups (Table 3).
Furthermore, there were no significant changes in the potency of rat
CGRP in isolated right atria after capsaicin pretreatment compared with
the control group (Figure, panel E). The maximum responses for
all studied agonists were similar in capsaicin-treated rats and the
control group (Table 3). Table 4
summarizes all studied agonists in isolated right atria from control
and capsaicin-treated rats.
|
|
| Discussion |
|---|
|
|
|---|
Many vascular tissues, including coronary vessels, are richly innervated by sensory fibers that, on stimulation, release substance P and CGRP.16 29 In the rat heart, substance P has no effect on vascular tone30 whereas CGRP exerts a potent vasodilatation.31 Capsaicin releases CGRP, leading to an enhancement of coronary flow.32 Maintenance of coronary vascular tone seems to be determined by endothelium-dependent and endothelium-independent mechanisms.33 Our findings showing a significant reduction of basal coronary flow in capsaicin-pretreated rats suggest that it is a consequence of CGRP depletion. In adult rats, systemic capsaicin treatment also reduces basal coronary flow.12
CGRP causes vasodilatation by a mechanism involving intracellular accumulation of cAMP34 that counteracts the norepinephrine-induced increase in inositol 1,4,5-trisphosphate levels.35 Thus, control of vascular tone in coronary vessels by CGRP may reflect a counterregulatory mechanism between these second messengers. Our results showing a decrease of basal coronary flow in the capsaicin-treated rats could be explained by a sustained decrease of cAMP levels. However, the lower responsiveness of coronary vessels to norepinephrine remains unclear.
CGRP has been described as a growth factor in the rat heart, where it exerts beneficial trophic actions on cardiomyocytes.1 Accordingly, our stereological studies have evidenced a decrease in cardiac muscle fiber size in capsaicin-treated rats. These results are therefore consistent with the suggestion that CGRP plays an important role in the maintenance of cardiomyocyte size under normal conditions by acting as a growth factor. Additionally, constant coronary flow as a consequence of continuous release of CGRP may also contribute to regulation of cardiac muscle fiber size. Reduction in coronary flow leads to an increase in the fibrous tissue in the heart as a result of ischemic processes.36 However, capsaicin-treated rats showed no alterations in the amount of fibrous tissues in the left ventricles, suggesting that the magnitude of the coronary flow reduction was insufficient to determine ischemic processes.
The positive chronotropic responses for isoproterenol, norepinephrine, and rat CGRP and the negative chronotropic responses for carbachol and pilocarpine were not affected in isolated right atria by capsaicin treatment. These results may be explained by the partial depletion (45%) of neuropeptides in our study. However, this is unlikely since previous work also found no alterations in the potency of both agonists, isoproterenol and rat CGRP, in right atria from guinea pigs and rats treated with capsaicin, where complete depletion of CGRP was detected.37 In a manner similar to that of chronotropism, capsaicin pretreatment had no effect on the inotropic responses to norepinephrine in isolated whole heart, indicating that cardiomyocytes may be able to retain their physiological responses, including contraction force, despite their size reduction. Taken together, these observations presumably indicate that sensory fibers do not play a role in the primary modulation of cardiac actions (chronotropism and inotropism) compared with the sympathetic nervous system, in which norepinephrine is the main neurotransmitter.
In summary, capsaicin treatment in neonatal rats causes a significant decrease of basal coronary flow, associated with diminishing cardiomyocyte size, as a consequence of CGRP depletion.
Received May 8, 1999; first decision June 22, 1999; accepted July 10, 1999.
| References |
|---|
|
|
|---|
2. Li YJ, Xiao ZS, Peng CF, Deng HW. Calcitonin gene-related peptide-induced preconditioning protects against ischemia-reperfusion injury in isolated rat hearts. Eur J Pharmacol. 1996;311:163167.[Medline] [Order article via Infotrieve]
3. Franco-Cereceda A, Lundberg JM. Calcitonin gene-related peptide (CGRP) and capsaicin-induced stimulation of heart contractile rate and force. Naunyn Schiedebergs Arch Pharmacol. 1985;331:146151.[Medline] [Order article via Infotrieve]
4. D'Alonzo AJ, Grover RB, Darbenzio RB, Hess PG, Sleph S, Dzwonczyk JL, Zhu JL, Sewter JC. In vitro effects of capsaicin: antiarrhythmic and antiischemic activity. Eur J Pharmacol. 1995;273:269272.
5. Ferdinandy P, Csont T, Csonka C, Torok M, Dux M, Nemeth J, Horvath LI, Dux L, Szilvassy Z, Jancsó G. Capsaicin-sensitive local sensory innervation is involved in pacing-induced preconditioning in rat hearts: role of nitric oxide and CGRP. Naunyn Schmiedbergs Arch Pharmacol. 1997;356:356363.[Medline] [Order article via Infotrieve]
6.
Burnstock G. Purinergic nerves. Pharmacol
Rev. 1972;24:509560.
7. Jancsó N, Jancsó-Gabor A, Szolcsanyi J. Direct evidence for neurogenic inflammation and its prevention by denervation and by treatment with capsaicin. Br J Pharmacol Chemother. 1967;31:138151.[Medline] [Order article via Infotrieve]
8. Jancsó N, Kiraly E, Jancsó-Gabor A. Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones. Nature. 1977;270:741743.[Medline] [Order article via Infotrieve]
9. Papka RE, Furness JB, Della NG, Costa M. Depletion by capsaicin of substance P-immunoreactivity and acetylcholinesterase activity from nerve fibres in the guinea-pig heart. Neurosci Lett. 1981;27:4753.[Medline] [Order article via Infotrieve]
10. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev. 1991;43:143201.[Medline] [Order article via Infotrieve]
11. Franco-Cereceda A, RudeHill A. Capsaicin-induced vasodilatation of human coronary arteries in vitro is mediated by calcitonin gene-related peptide rather than substance or neurokinin A. Acta Physiol Scand. 1989;136:575580.[Medline] [Order article via Infotrieve]
12.
Yaoita H, Sato E, Kawaguchi M, Saito T, Maehara K,
Maruyama Y. Nonadrenergic noncholinergic nerves
regulate basal coronary flow via release of capsaicin-sensitive
neuropeptides in the rat heart. Circ Res. 1994;75:780788.
13.
Sigrist S, Franco-Cereceda A, Muff R, Henke H, Lundberg
JM, Fisher JA. Specific receptor and cardiovascular
effects of calcitonin gene-related peptide. Endocrinology. 1986;119:381389.
14. Fukuda N, Fujiwara M. Effects of capsaicin on the guinea-pig isolated atrium. J Pharm Pharmacol. 1969;21:622623.[Medline] [Order article via Infotrieve]
15. Molnar J, Gyorgy L, Unyi G, Kenyeres J. Effects of capsaicin on the isolated ileum and auricle of the guinea-pig. Acta Physiol Acad Sci Hung. 1969;35:369374.[Medline] [Order article via Infotrieve]
16. Lündberg JM, Franco-Cereceda A, Hua X, Hokfelt T, Fusher JÁ. Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstriction effects of capsaicin. Eur J Pharmacol. 1985;108:315319.[Medline] [Order article via Infotrieve]
17. Franco-Cereceda A, Lundberg JM. Actions of calcitonin gene-related peptide and tachykinins in relation to the contractile effects of capsaicin in the guinea-pig and rat heart in vitro. Naunyn Schiedebergs Arch Pharmacol. 1988;337:649655.[Medline] [Order article via Infotrieve]
18. Franco-Cereceda A, Henke H, Lundberg JM, Petermann JB, Hökfelt T, Fisher JÁ. Calcitonin gene-related peptide in capsaicin-sensitive substance P-immunoreactivity sensory neurons in animals and man: distribution and release by capsaicin. Peptides. 1987;9:399410.
19. Ito H, Bell D, Tamamori M, Nozato T, Shimojo T, Adachi S, Abe S, Marumo F, Hiroe M. Calcitonin gene-related peptide (CGRP) and hypertrophy of cardiomyocytes. Heart Vessels. 1997;12:1517.
20. Trasforini G, Margutti A, Valentini A, Ambrosio MR, Bondanelli M, Rossi R, Pansini R, degli Uberti C. Interrelationships between calcitonin gene-related peptide and sympathoadrenomedullary system: effect of administration of epinephrine and norepinephrine in healthy man. Regul Pept. 1996;63:5761.[Medline] [Order article via Infotrieve]
21.
Rubino A, Ralevic V, Burnstock G. Sympathetic
neurotransmission in isolated rat atria after sensory-motor denervation
by neonatal treatment with capsaicin. J Pharmacol Exp
Ther. 1997;282:671675.
22. Kuo T, Ouchi Y, Kim S, Toba K, Orimo H. The role of activation of the sympathetic nervous system in the central pressor action of calcitonin gene-related peptide in conscious rats. Naunyn Schmiedebergs Arch Pharmacol. 1994;349:394400.[Medline] [Order article via Infotrieve]
23. Rubino A. Non-adrenergic non-cholinergic (NANC) neural control of the atrial myocardium. Gen Pharmacol. 1993;24:539545.[Medline] [Order article via Infotrieve]
24. Hughes IE, Smith JA. The stability of noradrenaline in physiological salt solutions. J Pharm Pharmacol. 1978;30:124126.[Medline] [Order article via Infotrieve]
25. Salt PJ. Inhibition of noradrenaline uptake2 in the isolated rat heart by steroids, clonidine and methoxylate phenethylamines. Eur J Pharmacol. 1972;20:329340.[Medline] [Order article via Infotrieve]
26. Van Rossum JM. Cumulative dose-response curves, II: technique for the making of dose-response curves in isolated organs and the evaluation of the drug parameters. Arch Int Pharmacodyn Ther. 1963;143:229330.
27. Aherne W. Quantitative methods in histology. J Med Lab Technol. 1970;27:160170.[Medline] [Order article via Infotrieve]
28. Zatz R. A low cost tail-cuff method for the estimation of mean arterial pressure in conscious rats. Lab Anim Sci. 1990;40:198201.[Medline] [Order article via Infotrieve]
29.
Lundberg JM, Tatemoto K. Pancreatic polypeptide family
(APP, BPP, NPY, and PYY) in relation to sympathetic vasoconstriction
resistant to
-adrenoceptor blockade. Acta Physiol
Scand. 1982;116:393402.[Medline]
[Order article via Infotrieve]
30. Kulakowski EC, Lampson WG, Schaffer SW, Lovenberg W. Action of substance P on the working rat heart. Biochem Pharmacol. 1985;32:10972090.
31. Brain SD, Williams TJ, Tippins JR, Morris HR, MacIntyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature. 1985;313:54-56.[Medline] [Order article via Infotrieve]
32. Franco-Cereceda A. Resiniferatoxin-, capsaicin- and CGRP-evoked porcine coronary vasodilatation is independent of EDRF mechanisms but antagonized by CGRP(837). Acta Physiol Scand. 1991;143:331337.[Medline] [Order article via Infotrieve]
33. Prieto D, Benedito S, Nyborg NCB. Heterogenous involvement of endothelium in calcitonin gene-related peptide-induced relaxation in coronary arteries from rat. Br J Pharmacol. 1991;103:17641768.[Medline] [Order article via Infotrieve]
34. Fiscus RR, Zhou HL, Wang X, Han C, Ali S, Joyce CD, Murad F. Calcitonin-gene related peptide (CGRP)-induced cyclic AMP, cyclic GMP and vasorelaxant responses in rat thoracic aorta are antagonized by blockers of endothelium-derived relaxant factor (EDRF). Neuropeptides. 1991;20:133143.[Medline] [Order article via Infotrieve]
35. Yousufzai SY, Abdel-Latif AA. Calcitonin gene-related peptide relaxes rabbit iris dilator smooth muscle via cyclic AMP-dependent mechanisms: cross-talk between the sensory and sympathetic nervous systems. Curr Eye Res. 1998;17:197204.[Medline] [Order article via Infotrieve]
36. Moreno H Jr, Metze K, Bento AC, Antunes E, Zatz R, De Nucci G. Chronic nitric oxide inhibition as a model of hypertensive heart muscle disease. Basic Res Cardiol. 1996;91:248255.[Medline] [Order article via Infotrieve]
37. Franco-Cereceda A, Lundberg JR, Saria A, Schreibmayer W, Tritthart HA. Calcitonin gene-related peptide: release by capsaicin and prolongation of the action potential in the guinea-pig heart. Acta Physiol Scand. 1988;132:181190.[Medline] [Order article via Infotrieve]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |